Viewing nowCombinationTwinact Tablet 40/10 Milligrams
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.

MFDS item code 201605706 · Approved 2016.09.29 · Insurance code 678600690
Treatment of essential hypertension not controlled with monotherapy
For patients with essential hypertension, if blood pressure is not sufficiently controlled with monotherapy of Amlodipine or Telmisartan, this medication can effectively control blood pressure. It helps lower blood pressure steadily, thereby reducing the risk of cardiovascular complications. Therefore, it is recommended as a suitable treatment option for patients with hypertension who have difficulty managing their blood pressure.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, it is recommended that treatment be initiated at a low dose in patients with severe renal impairment, with gradual dose increases. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: Administration of this drug is not recommended in pediatric patients aged 18 years or younger because safety and efficacy have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be used by pregnant women or women who may become pregnant. It should not be administered to individuals with allergies to the active substance or similar components, those with severely impaired liver or heart function, severe hypotension patients, or unstable patients following acute myocardial infarction. Patients with specific conditions, such as primary aldosteronism, heart valve disease, liver disorders, gastrointestinal diseases, renal issues, and the elderly, should use this medication cautiously and follow their doctor’s instructions strictly. During treatment with this medication, side effects such as dizziness and peripheral edema may frequently occur, and serious side effects have been reported rarely. If any unusual symptoms appear, immediate consultation with healthcare professionals is necessary. This medication should not be taken during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and replaced with other safe treatments. It can lower blood pressure suddenly, so patients at high risk of hypotension should manage their condition well before taking this medication, and if hypotensive symptoms appear, they should seek appropriate measures. There is a risk of elevated blood potassium levels, so caution is needed when used with potassium supplements or potassium-containing foods, and regular blood tests are recommended. Patients with impaired renal function should frequently monitor their kidney function while taking this medication, and there is insufficient experience with transplant patients. Patients with heart disease need to be cautious as the risk of angina or myocardial infarction may increase when taking this medication. This medication may cause drowsiness or dizziness, so caution is required when driving or operating hazardous machinery. It may interact with other medications, so especially when taken with lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs, consultation with a doctor or pharmacist is necessary. This medication contains sorbitol, so it should be avoided by patients with fructose intolerance. In cases of overdose, symptoms such as hypotension, arrhythmias, and acute kidney failure may occur, requiring immediate medical treatment. It is not recommended for children as safety and efficacy have not been established in pediatric patients under 18 years of age. Elderly patients may react more sensitively to this medication, so it should be started at a low dose and gradually increased.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light in. Additionally, it is important to keep it at a temperature between 1°C and 30°C to maintain its effectiveness.
A white and light gray biconvex oval double tablet.
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
(Co., Ltd.) CMG Pharmaceutical
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.